Verdad Advisers, LP — 13F Holdings & Portfolio
CIK 1812822 · latest 13F-HR filed 2026-08-14
Verdad Advisers, LP manages $104.4M in 13F-reported U.S. long-equity assets across 210 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AAPL (2.06%), BLTE (2.03%), ACAD (2.00%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 97 new positions, exited 66, added to 62, and trimmed 45.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
4TH FLOOR
BOSTON, MA 02111
$104.4M
Long-equity book
210
Distinct positions
2026-06-30
Filed 2026-08-14
+97 / −66 / ↑62 / ↓45
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- SLIDE INS HLDGS INC$1.2M +219.7%
- WHITEHAWK THERAPEUTICS INC$982.4K +246.6%
- NETSCOUT SYS INC$974.7K +208.3%
- COMCAST CORP NEW$883.3K +74.0%
- VERSANT MEDIA GROUP INC$863.3K +122.8%
Top Trims
- REVOLUTION MEDICINES INC-$1.3M -63.8%
- ZOOM COMMUNICATIONS INC-$1.1M -64.6%
- CALIFORNIA RES CORP-$1.0M -66.1%
- MICRON TECHNOLOGY INC-$814.0K -62.7%
- LAM RESEARCH CORP-$716.2K -64.9%
New Positions
- APPLE INC$2.2M
- X4 PHARMACEUTICALS INC$1.6M
- JADE BIOSCIENCES INC$1.3M
- CISCO SYS INC$1.2M
- PROTARA THERAPEUTICS INC$1.2M
Exited Positions
- STATE STR CORP$2.1M
- AUTOHOME INC$2.1M
- CAL MAINE FOODS INC$2.0M
- AXSOME THERAPEUTICS INC.$1.0M
- CHEVRON CORPORATION$936.2K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | APPLE INC | AAPL | 037833100 | $2.2M | 2.06% | 7,445 | SH |
| 2 | BELITE BIO INC | BLTE | 07782B104 | $2.1M | 2.03% | 13,758 | SH |
| 3 | ACADIA PHARMACEUTICALS INC | ACAD | 004225108 | $2.1M | 2.00% | 82,629 | SH |
| 4 | COMCAST CORP NEW | CMCSA | 20030N101 | $2.1M | 1.99% | 84,569 | SH |
| 5 | CHATHAM LODGING TR | CLDT | 16208T102 | $1.9M | 1.77% | 140,000 | SH |
| 6 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $1.8M | 1.72% | 123,174 | SH |
| 7 | SLIDE INS HLDGS INC | SLDE | 831349105 | $1.8M | 1.69% | 91,070 | SH |
| 8 | ZYMEWORKS INC | ZYME | 98985Y108 | $1.7M | 1.67% | 66,688 | SH |
| 9 | AMN HEALTHCARE SVCS INC | AMN | 001744101 | $1.7M | 1.61% | 51,906 | SH |
| 10 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $1.6M | 1.57% | 352,093 | SH |
| 11 | VERSANT MEDIA GROUP INC | VSNT | 925283103 | $1.6M | 1.50% | 43,503 | SH |
| 12 | NETSCOUT SYS INC | NTCT | 64115T104 | $1.4M | 1.38% | 33,128 | SH |
| 13 | WHITEHAWK THERAPEUTICS INC | WHWK | 00032Q104 | $1.4M | 1.32% | 301,483 | SH |
| 14 | JOHNSON & JOHNSON | JNJ | 478160104 | $1.4M | 1.31% | 5,384 | SH |
| 15 | CONTINEUM THERAPEUTICS INC | CTNM | 21217B100 | $1.3M | 1.27% | 81,014 | SH |
| 16 | JADE BIOSCIENCES INC | JBIO | 008064206 | $1.3M | 1.20% | 56,384 | SH |
| 17 | CISCO SYS INC | CSCO | 17275R102 | $1.2M | 1.16% | 10,307 | SH |
| 18 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | $1.2M | 1.15% | 49,511 | SH |
| 19 | PROTARA THERAPEUTICS INC | TARA | 74365U107 | $1.2M | 1.14% | 312,249 | SH |
| 20 | BLOOMIN BRANDS INC | BLMN | 094235108 | $1.2M | 1.14% | 130,000 | SH |
| 21 | TYRA BIOSCIENCES INC | TYRA | 90240B106 | $1.1M | 1.10% | 36,003 | SH |
| 22 | PAR PAC HOLDINGS INC | PARR | 69888T207 | $1.1M | 1.07% | 20,000 | SH |
| 23 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $1.1M | 1.06% | 27,234 | SH |
| 24 | ALPHABET INC | GOOGL | 02079K305 | $1.0M | 0.99% | 2,900 | SH |
| 25 | CARTERS INC | CRI | 146229109 | $1.0M | 0.99% | 25,000 | SH |
| 26 | VERA THERAPEUTICS INC | VERA | 92337R101 | $1.0M | 0.97% | 23,487 | SH |
| 27 | NUVALENT INC | NUVL | 670703107 | $1.0M | 0.96% | 8,104 | SH |
| 28 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $980.8K | 0.94% | 10,062 | SH |
| 29 | ACLARIS THERAPEUTICS INC | ACRS | 00461U105 | $927.2K | 0.89% | 175,272 | SH |
| 30 | OPPENHEIMER HLDGS INC | OPY | 683797104 | $915.3K | 0.88% | 8,673 | SH |
| 31 | VERIZON COMMUNICATIONS INC | VZ | 92343V104 | $886.5K | 0.85% | 20,938 | SH |
| 32 | MYERS INDS INC | MYE | 628464109 | $865.1K | 0.83% | 24,500 | SH |
| 33 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $860.6K | 0.82% | 16,957 | SH |
| 34 | UNIVERSAL INS HLDGS INC | UVE | 91359V107 | $850.3K | 0.81% | 20,558 | SH |
| 35 | BANK OF NY MELLON CORP | BNY | 064058100 | $831.2K | 0.80% | 5,748 | SH |
| 36 | PC CONNECTION INC | CNXN | 69318J100 | $809.0K | 0.77% | 11,084 | SH |
| 37 | AMERICAN INTEGRITY INS GROUP | AII | 026948109 | $794.2K | 0.76% | 42,178 | SH |
| 38 | APPLIED MATLS INC | AMAT | 038222105 | $787.3K | 0.75% | 1,089 | SH |
| 39 | ADAPTHEALTH CORP | AHCO | 00653Q102 | $781.5K | 0.75% | 75,000 | SH |
| 40 | ALLSTATE CORP | ALL | 020002101 | $780.2K | 0.75% | 3,279 | SH |
| 41 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $770.4K | 0.74% | 20,704 | SH |
| 42 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $759.0K | 0.73% | 4,053 | SH |
| 43 | HERITAGE INSURANCE HLDGS INC | HRTG | 42727J102 | $745.2K | 0.71% | 28,575 | SH |
| 44 | TD SYNNEX CORPORATION | SNX | 87162W100 | $743.2K | 0.71% | 2,780 | SH |
| 45 | MOVADO GROUP INC | MOV | 624580106 | $737.5K | 0.71% | 18,762 | SH |
| 46 | SMART SAND INC | SND | 83191H107 | $714.8K | 0.68% | 142,684 | SH |
| 47 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $711.3K | 0.68% | 38,722 | SH |
| 48 | DESIGN THERAPEUTICS INC | DSGN | 25056L103 | $688.1K | 0.66% | 47,557 | SH |
| 49 | MARCUS & MILLICHAP INC | MMI | 566324109 | $684.9K | 0.66% | 21,972 | SH |
| 50 | MATIV HOLDINGS INC | MATV | 808541106 | $681.3K | 0.65% | 90,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $104.4M | 210 | 0001420506-26-001697 |
| 2026-03-31 | 2026-05-15 | $88.8M | 179 | 0001420506-26-001092 |
| 2025-12-31 | 2026-02-17 | $87.4M | 104 | 0001420506-26-000495 |
| 2024-09-30 | 2024-11-14 | $74.9M | 93 | 0001420506-24-002479 |